Skip to main content
Equibles

Parallel Advisors, LLC

Position in NVS — Novartis AG

CIK 1690010 SAN FRANCISCO, CA
Back to NVS Full portfolio

Position in NVS

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$2,451,100
-$48,806 QoQ
Shares Held
15,640
-4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#389
of 1,609 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $119,634,223 across 18 Drug Manufacturers - General names. NVS ranks #8 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 31,933 $38,301,401
2 ABBV
AbbVie Inc.
 100,846 $25,376,887
3 JNJ
Johnson & Johnson
 83,035 $21,088,398
4 GILD
Gilead Sciences, Inc.
 76,862 $9,710,745
5 MRK
Merck & Co., Inc.
 66,774 $8,580,459
6 AMGN
Amgen Inc
 11,139 $4,033,654
7 NVO
Novo Nordisk A S
 56,877 $2,726,683
8 NVS
Novartis AG
This page 		15,640 $2,451,100

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,451,100 15,640
2026-03-31 $2,499,906 16,366
2025-12-31 $1,740,470 12,624
2025-09-30 $1,599,922 12,476
2025-06-30 $1,467,246 12,125
2025-03-31 $1,430,399 12,831
2024-12-31 $1,402,918 14,417
2024-09-30 $1,601,193 13,921
2024-06-30 $1,378,231 12,946
2024-03-31 $1,165,596 12,050
2023-12-31 $895,704 8,871
2023-09-30 $927,537 9,106
2023-06-30 $888,815 8,808
2023-03-31 $740,232 8,046
2022-12-31 $665,975 7,341
2022-09-30 $562,778 7,404
2022-06-30 $691,032 8,175
2022-03-31 $904,965 10,313
2021-12-31 $1,049,377 11,997
2021-09-30 $1,136,496 13,897
2021-06-30 $1,074,259 11,774
2021-03-31 $708,629 8,290
2020-12-31 $736,931 7,804
2020-09-30 $664,983 7,647
2020-06-30 $595,047 6,813
2020-03-31 $443,168 5,375